COVID19-OR (SARS-CoV-2): Observation,Risk & Recovery
COVID19-OR (SARS-CoV-2):Observation, Risk & Recovery. An Observational Study Exploring Risk Assessment and Recovery From COVID-19 (SARS-CoV-2) Infection in Hospitalised Patients
1 other identifier
observational
194
1 country
1
Brief Summary
A novel coronavirus, designated corona virus disease 2019 (COVID-19) has resulted in a Pandemic at the time of writing (27th April) the reported number of confirmed cases exceeding 3 million and over 200000 associated deaths. The burden on global critical care has been considerable. As of 24th April there have been 8752 UK critical care admissions with services under considerable strain, and a mortality rate over 50%. Survivors of critical illness will require significant input. This study will perform mixed methods to provide rich data on risk stratification and recovery from critical illness. Recovery from a novel disease requires documenting and the study reports physical and psychological changes following hospital discharge in survivors. In addition qualitative interviews are being conducted with patients who have survived and been discharged from critical care along with their relatives and treating professionals, to better understand their needs during recovery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 5, 2020
CompletedFirst Submitted
Initial submission to the registry
August 19, 2020
CompletedFirst Posted
Study publicly available on registry
August 24, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 8, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 8, 2022
CompletedJuly 18, 2022
July 1, 2022
2 years
August 19, 2020
July 15, 2022
Conditions
Outcome Measures
Primary Outcomes (9)
Physical
Chelsea critical care physical assessment tool
through study completion , an average of 1 year
Physical
Incremental Shuttle Walk Test (ISWT)
through study completion , an average of 1 year
Physical
1- minute Sit to Stand, Grip strength
through study completion , an average of 1 year
Health Related Quality of life
Short Form Survey on health related quality of life (SF-12). Two summary scores are reported from the SF-12 - a mental component score (MCS-12) and a physical component score (PCS-12). The scores may be reported as Z-scores (difference compared to the population average, measured in standard deviations). The United States population average PCS-12 and MCS-12 are both 50 points. Higher scores indicate better outcome.
at 3 months
Health Related Quality of life
Short Form Survey on health related quality of life (SF-36). Scores can range from 0 to 100 and a higher score indicates better outcome.
at 1 year
Psychological
Depression Test Questionnaire (PHQ-9). Scores range from 1 to 27 and higher scores indicate worse outcome.
through study completion , an average of 1 year
Psychological
Anxiety Test Questionnaire (GAD-7). Scores range from 0 to 21 and higher scores indicates worse outcome.
through study completion , an average of 1 year
Psychological
Montreal Cognitive Assessment (MoCA). Scores range from 0 to 30 and higher scores indicate a better outcome.
through study completion , an average of 1 year
Psychological
Post-traumatic stress disorder (PTSD) Trauma Screening (TSQ). A screening tool with 10 items. If 6 items are endorsed then the outcome is 'positive' for PTSD.
at 1 year
Secondary Outcomes (3)
risk stratification
through study completion and average of 1 year
risk stratification
through study completion and average of 1 year
risk stratification
through study completion and average of 1 year
Eligibility Criteria
Adults admitted to hospital with suspected/confirmed COVID-19.
You may qualify if:
- Adults ≥18 years admitted to ICU with SARS-CoV-2 and survived
- Relatives or friends and professionals involved in the care of these patients.
You may not qualify if:
- Patients \<18 years;
- Patients with a negative test for SARS-CoV-2 or patients not tested due to absence of symptoms;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dr Luke Hodgson
Worthing, United Kingdom
Study Officials
- PRINCIPAL INVESTIGATOR
Dr Luke Hodgson
Western Sussex Hospitals NHS Trust
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 19, 2020
First Posted
August 24, 2020
Study Start
May 5, 2020
Primary Completion
May 8, 2022
Study Completion
June 8, 2022
Last Updated
July 18, 2022
Record last verified: 2022-07